Quick Answer: Allergic reactions to tirzepatide range from mild local injection site reactions to serious systemic hypersensitivity including anaphylaxis and angioedema, which are contraindications to continued use
When people take semaglutide to lose weight and fluoxetine to manage their mental health, they might wonder how the two treatments interact
Tier III Third-party lab Tier III Third-party lab External independent HPLC, ICP-MS, and microbiology by accredited lab
The only GLP-1 based treatments proven to support weight loss in the UK are prescription-only medications that have been approved by regulators such as the Medicines and Healthcare products Regulatory Agency (MHRA)
It is marketed under two brand names with an identical active ingredient but different indications: Mounjaro (approved May 2022): for blood-sugar control in type 2 diabetes mellitus, alongside diet and exercise
Food and Drug Administration (FDA)-approved glucagon-like peptide-1 receptor agonists (GLP-1) anti-obesity medications, such as Zepbound and Wegovy , are flying off pharmacy shelves